Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25925
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBroadley, James-
dc.contributor.authorWesselingh, Robb-
dc.contributor.authorSeneviratne, Udaya-
dc.contributor.authorKyndt, Chris-
dc.contributor.authorBeech, Paul-
dc.contributor.authorBuzzard, Katherine-
dc.contributor.authorNesbitt, Cassie-
dc.contributor.authorD'souza, Wendyl-
dc.contributor.authorBrodtmann, Amy-
dc.contributor.authorMacdonell, Richard A L-
dc.contributor.authorKalincik, Tomas-
dc.contributor.authorButzkueven, Helmut-
dc.contributor.authorO'Brien, Terence J-
dc.contributor.authorMonif, Mastura-
dc.date2021-01-30-
dc.date.accessioned2021-02-22T23:52:03Z-
dc.date.available2021-02-22T23:52:03Z-
dc.date.issued2021-04-15-
dc.identifier.citationJournal of Neuroimmunology 2021; 353: 577508en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/25925-
dc.description.abstractTo examine the prognostic value of CSF abnormalities in seropositive autoimmune encephalitis (AE). We retrospectively studied 57 cases of seropositive AE. Primary outcomes were mortality and modified Rankin Scale, while secondary outcomes were first line treatment failure, ICU admission and relapse. Regression analysis was performed. CSF white cell count (WCC) was higher in the NMDAR group, while elevated protein was more common amongst other subtypes. We found an association between WCC >5 cells/mm3 and treatment failure (OR 16.0, p = 0.006)), and between WCC >20 cells/mm3 and ICU admission (OR 19.3, p = 0.026). Different subsets of AE have characteristic CSF abnormalities, which may aid recognition during early evaluation. CSF WCC had prognostic significance in our study.en
dc.language.isoeng
dc.subjectAutoimmune encephalitisen
dc.subjectBiomarkeren
dc.subjectCSFen
dc.subjectLymphocytosisen
dc.subjectPrognosisen
dc.titlePrognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Neuroimmunologyen
dc.identifier.affiliationDepartment of Physiology, The University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Radiology, Monash Health, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Neuroscience, Barwon Health, Geelong, Australiaen
dc.identifier.affiliationDepartment of Medicine, St Vincent's Hospital, University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Neuroscience, Monash University, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Neurology, Alfred Health, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Medicine, The University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationCORe, The University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Neurology, Melbourne Health, Melbourne, Australiaen
dc.identifier.affiliationNeurologyen
dc.identifier.affiliationDepartment of Neurosciences, Eastern Health, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Neuroscience, Monash Health, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Radiology, Alfred Health, Melbourne, Australiaen
dc.identifier.doi10.1016/j.jneuroim.2021.577508en
dc.type.contentTexten
dc.identifier.pubmedid33588218
local.name.researcherBrodtmann, Amy
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptNeurology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

38
checked on Nov 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.